<https://rdf.molmedb.upol.cz/reference/ref336> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM16748>;
	<http://purl.org/ontology/bibo/pmid> "8421289"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1021/jm00053a006"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target43>,
		<https://rdf.molmedb.upol.cz/transporter/target44>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00857>;
	<http://purl.org/dc/terms/bibliographicCitation> "Templeton JF, Ling Y, Zeglam TH, LaBella FS.: Synthesis of 20-hydroxy-, 20-amino-, and 20-nitro-14-hydroxy-21-nor-5 beta,14 beta-pregnane C-3 glycosides and related derivatives: structure-activity relationships of pregnanes that bind to the digitalis receptor. J Med Chem, Volume 36 (1), 1993"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra56586> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref336> .
<https://rdf.molmedb.upol.cz/transporter/tra56581> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref336> .
<https://rdf.molmedb.upol.cz/transporter/tra56713> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref336> .
<https://rdf.molmedb.upol.cz/transporter/tra56712> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref336> .
